Considering Genetic Risk in Prostate Cancer Referrals Could Lead to Early Diagnosis
Men at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practice.
Read MorePosted by Andy Lundin | Aug 19, 2022 | Prostate |
Men at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practice.
Read MorePosted by Andy Lundin | Aug 18, 2022 | Dementias & Alzheimer’s |
A new study identified multiple new risk genes for Alzheimer’s disease and a rare, related brain disorder through new testing methods.
Read MorePosted by Andy Lundin | Aug 16, 2022 | Company News, Womens Health |
Nanopath will develop & commercialize a biosensing platform that aims to transform how women’s pelvic & gynecologic infections are diagnosed.
Read MorePosted by Andy Lundin | Aug 16, 2022 | Covid 19, Rapid Assays |
Researchers have created an easy-to-use diagnostic test for COVID infection that is more sensitive than commonly used at-home antigen tests.
Read MorePosted by Andy Lundin | Aug 11, 2022 | Uncategorized |
Natera has proactively filed a pre-submission to the FDA for its Panorama non-invasive prenatal test (NIPT) as part of the Q-Sub process.
Read More